<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05084742</url>
  </required_header>
  <id_info>
    <org_study_id>BIOD2021-03</org_study_id>
    <secondary_id>2021-A01631-40</secondary_id>
    <nct_id>NCT05084742</nct_id>
  </id_info>
  <brief_title>Long-term Performance and Safety of Biodentine™ in Patients Treated for Endodontic Indications</brief_title>
  <official_title>Observational Clinical Trial, Prospective and Multicenter, Measuring the Long-term Performance and Safety of Biodentine™ in Patients Treated for Endodontic Indications</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Septodont</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>EndoData</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>ReCOL</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>QualityStat</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Septodont</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this observational, retro-prospective, and multicenter PMCF clinical investigation,&#xD;
      Biodentine™, an active dentine substitute for professional dental use only, is evaluated at&#xD;
      10 years post-treatment, in its endodontic indications as followed:&#xD;
&#xD;
        -  Repair of root or furcation perforations.&#xD;
&#xD;
        -  Repair of root resorptions (internal and external).&#xD;
&#xD;
        -  Root-end filling in endodontic surgery (retrograde filling).&#xD;
&#xD;
        -  Apexification (tooth with open apex).&#xD;
&#xD;
      Evaluation is done through a 10-year post-treatment follow-up with collection of&#xD;
      radiographic, clinical examination and safety data.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 8, 2021</start_date>
  <completion_date type="Anticipated">September 2030</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical and radiographic success of treatment</measure>
    <time_frame>At 10 years post-treatment</time_frame>
    <description>The proportion of patients with successfull treatment at 10 years post-surgery will be determined on clinical and radiographic success evidences for each endodontic indication of Biodentine™:&#xD;
In root end-filling&#xD;
In root resorption repair (internal, external)&#xD;
In root and furcation perforation repair&#xD;
In apexification</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Adverse Events (AE) and device deficiencies</measure>
    <time_frame>From treatment onset to 10 years post-treatment</time_frame>
    <description>Safety at 10 years post-surgery will be determined based on the cumulative numbers of Adverse Events (AE) and device deficiencies observed from treatment onset to 10 years post-treatment, for each endodontic indication of Biodentine™:&#xD;
In root end-filling&#xD;
In root resorption repair (internal, external)&#xD;
In root and furcation perforation repair&#xD;
In apexification</description>
  </secondary_outcome>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Endodontically Treated Teeth</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Biodentine™</intervention_name>
    <description>Biodentine™ is a bioactive dentin substitute from the &quot; Active Biosilicate Technology® &quot; innovation.&#xD;
Study participants were treated between 01mar2016 and 30Sept2020 with an endodontic microsurgery using Biodentine™ used in its endodontic indications, i.e., root end-filling, external or internal root resorption repair, root and furcation perforation repair, and apexification.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        160 patients with a permanent tooth treated between 01 March 2016 and 30 September 2020&#xD;
        with an endodontic microsurgery using Biodentine™, all microsurgery including root&#xD;
        end-filling, external or internal root resorption repair, root and furcation perforation&#xD;
        repair and apexification.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or female, adults or children with permanent teeth (immature or mature)&#xD;
&#xD;
          -  Treated with an endodontic microsurgery using Biodentine™: all microsurgery including&#xD;
             root end-filling, external or internal root resorption repair, root and furcation&#xD;
             perforation repair and apexification&#xD;
&#xD;
          -  Patients treated between 01 March 2016 and 30 September 2020&#xD;
&#xD;
          -  Availability of baseline radiographic images&#xD;
&#xD;
          -  Patients affiliated to national health insurance&#xD;
&#xD;
          -  Patients informed about the study and who consent to participate to the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients treated with anti-cancer therapy in the 5 years prior to the treatment&#xD;
&#xD;
          -  Uncontrolled systemic disease 1 month prior to the treatment&#xD;
&#xD;
          -  Development of a cancer or a systemic disease just after the treatment&#xD;
&#xD;
          -  Participation to an interventional clinical trial at the time of the treatment&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brigitte Grosgogeat, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>CHU de Lyon, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marie Georgelin Gurgel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Toulouse, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Anne-Margaux Collignon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>AP-HP, Hôpital Louis Mourier, Colombes, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alexis Gaudin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Nantes, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Cyril Villat, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>HCL de Lyon, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marie-Paule Gellé, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Reims, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sandrine Dahan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Private dental practice, Paris, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Grégory Caron, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Private dental practice, Paris, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Cauris Couvrechel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Private dental practice, Paris, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Farid Benabdallah, MD</last_name>
    <phone>+33 (0)149767328</phone>
    <email>fbenabdallah@septodont.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Raphaël H Haddad</last_name>
    <phone>+33676750457</phone>
    <email>rhaddad@septodont.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>AP-HP, Hôpital Louis Mourier</name>
      <address>
        <city>Colombes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anne-Margaux Collignon, MD</last_name>
    </contact>
    <investigator>
      <last_name>Anne-Margaux Collignon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marie Sevin, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>HCL de Lyon</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cyril Villat, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Cyril Villat, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Raphaël Richert, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Nantes</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexis Gaudin, MD</last_name>
    </contact>
    <investigator>
      <last_name>Alexis Gaudin</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Private dental care office</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandrine Dahan, MD</last_name>
    </contact>
    <investigator>
      <last_name>Sandrine Dahan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Private dental care office</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Grégory Caron, MD</last_name>
    </contact>
    <investigator>
      <last_name>Grégory Caron, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Private dental care office</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cauris Couvrechel, MD</last_name>
    </contact>
    <investigator>
      <last_name>Cauris Couvrechel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Reims</name>
      <address>
        <city>Reims</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marie-Paule Gellé, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Marie-Paule Gellé, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Toulouse</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marie Georgelin Gurgel, MD</last_name>
    </contact>
    <investigator>
      <last_name>Marie Georgelin Gurgel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>October 6, 2021</study_first_submitted>
  <study_first_submitted_qc>October 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 20, 2021</study_first_posted>
  <last_update_submitted>November 10, 2021</last_update_submitted>
  <last_update_submitted_qc>November 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tooth, Nonvital</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

